The type of feto-placental aneuploidy detected by cfDNA testing may influence the choice of confirmatory diagnostic procedure

Prenatal Diagnosis

Volumn 35, Issue 10, 2015, Pages 994-998

  Grati, Francesca Romana ^a   Bajaj, Komal ^b   Malvestiti, Francesca ^a   Agrati, Cristina ^a   Grimi, Beatrice ^a   Malvestiti, Barbara ^a   Pompilii, Eva ^a   Maggi, Federico ^a   Gross, Susan ^b,c   Simoni, Giuseppe ^a   Ferreira, Jose Carlos P ^b,d  

^a TOMA Advanced Biomedical Assays SpA   (Italy)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c NATERA INC   (United States)

^d MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AMNIOCENTESIS; ANEUPLOIDY; ARTICLE; CELL FREE DNA TESTING; CHORION VILLUS SAMPLING; CONTROLLED STUDY; CYTOTROPHOBLAST; DESCRIPTIVE RESEARCH; DIAGNOSTIC TEST ACCURACY STUDY; FETUS; FETUS CIRCULATION; FETUS DISEASE; GENETIC SCREENING; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPE; MAJOR CLINICAL STUDY; MATERNAL PLASMA; MESENCHYME CELL; MONOSOMY X; MOSAICISM; NON INVASIVE MEASUREMENT; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TRISOMY 13; TRISOMY 18; TRISOMY 21; FEMALE; LABORATORY DIAGNOSIS; MATERNAL SERUM SCREENING TEST; PREGNANCY; TRISOMY;

FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MATERNAL SERUM SCREENING TESTS; MOSAICISM; PREGNANCY; RETROSPECTIVE STUDIES; TRISOMY;

EID: 84943352742     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4659     Document Type: Article

References (21)

1. Gil MM, Akolekar R, Quezada MS, et al. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: meta-analysis. Fetal Diagn Ther 2014;35:156-73.
2. Gil MM, Quezada MS, Revello R, et al. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol 2015;45:249-66.
3. Tjoa ML, Cindrova-Davies T, Spasic-Boskovic O, et al. Trophoblastic oxidative stress and the release of cell-free feto-placental DNA. Am J Pathol 2006;169:400-4.
4. Flori E, Doray B, Gautier E, et al. Circulating cell-free fetal DNA in maternal serum appears to originate from cyto- and syncytio-trophoblastic cells. Case Report Hum Reprod 2004;19:723-4.
5. Faas BH, de Ligt J, Janssen I, et al. Non-invasive prenatal diagnosis of fetal aneuploidies using massively parallel sequencing-by-ligation and evidence that cell-free fetal DNA in the maternal plasma originates from cytotrophoblastic cells. Expert Opin Biol Ther 2012;12(Suppl 1):S19-26.
6. Kalousek DK, Vekemans M. Confined placental mosaicism. J Med Genet 1996;33:529-33.
7. Hahnemann JM, Vejerslev LO. European collaborative research on mosaicism in CVS (EUCROMIC)-fetal and extrafetal cell lineages in 192 gestations with CVS mosaicism involving single autosomal trisomy. Am J Med Genet 1997;70:179-87.
8. Hall AL, Drendel HM, Verbrugge JL, et al. Positive cell-free fetal DNA testing for trisomy 13 reveals confined placental mosaicism. Genet Med 2013;15:729-32.
9. Pan Q, Sun B, Huang X, et al. A prenatal case with discrepant findings between non-invasive prenatal testing and fetal genetic testings. Mol Cytogenet 2014;7:48-53.
10. Chen X, Dai M, Shi W, et al. Analysis of two false positive cases from noninvasive prenatal testing. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2014;31:778-81.
11. Chen C, Cram DS, Xie F, et al. A pregnancy with discordant fetal and placental chromosome 18 aneuploidies revealed by invasive and noninvasive prenatal diagnosis. Reprod Biomed Online 2014;29:136-9.
12. Mao J, Wang T, Wang BJ, et al. Confined placental origin of the circulating cell free fetal DNA revealed by a discordant non-invasive prenatal test result in a trisomy 18 pregnancy. Clin Chim Acta 2014;433:190-3.
13. Zhang H, Gao Y, Jiang F, et al. Noninvasive prenatal testing for trisomy 21, 18 and 13-clinical experience from 146, 958 pregnancies. Ultrasound Obstet Gynecol 2015. DOI:10.1002/uog.14792.
14. Choi H, Lau TK, Jiang FM, et al. Fetal aneuploidy screening by maternal plasma DNA sequencing: "false positive" due to confined placental mosaicism. Prenat Diagn 2013;33:198-200.
15. Pan M, Li FT, Li Y, et al. Discordant results between fetal karyotyping and non-invasive prenatal testing by maternal plasma sequencing in a case of uniparental disomy 21 due to trisomic rescue. Prenat Diagn 2013;33:598-601.
16. Futch T, Spinosa J, Bhatt S, et al. Initial clinical laboratory experience in noninvasive prenatal testing for fetal aneuploidy from maternal plsma DNA samples. Prenat Diagn 2013;33:569-74.
17. Borrell A, Stergiotou I. Cell-free DNA testing: inadequate implementation of an outstanding technique. Ultrasound Obstet Gynecol 2015. DOI:10.1002/uog.14795.
18. Grati FR. Chromosomal mosaicism in human feto-placental development: implications for prenatal diagnosis. J Clin Med 2014;3:809-37.
19. Grati FR, Malvestiti F, Ferreira JC, et al. Fetoplacental mosaicism: potential implications for false-positive and false-negative noninvasive prenatal screening results. Genet Med 2014;16:620-4.
20. Newcombe RG. Interval estimation for the difference between independent proportions: comparison of eleven methods. Stat Med 1998;17:873-90.
21. Mennuti MT, Cherry AM, Morrissette JJ, Dugoff L. Is it time to sound an alarm about false-positive cell-free DNA testing for fetal aneuploidy? Am J Obstet Gynecol 2013;209:415-9.